Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: A comparative animal study
- 1 October 1996
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 23 (7) , 897-906
- https://doi.org/10.1016/s0969-8051(96)00122-9
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Mapping the biodistribution and catabolism of 5‐fluorouracil in tumor‐bearing rats by chemical‐shift selective 19F MR imagingMagnetic Resonance in Medicine, 1995
- Drug-specific /sup 19/F NMR and dynamic /sup 18/F PET imaging of the cytostatic agent 5-fluorouracilIEEE Transactions on Nuclear Science, 1994
- Selective 19F MR imaging of 5-fluorouracil and α-fluoro-β-alanineMagnetic Resonance Imaging, 1993
- Perfusion of colorectal liver metastases and uptake of fluorouracil assessed by H215O and [18F]uracil positron emission tomography (PET)European Journal Of Cancer, 1993
- Scatter correction in the transaxial slices of a whole-body positron emission tomographPhysics in Medicine & Biology, 1993
- Comparison of 5-Fluorouracil pharmacokinetics following intraperitoneal and intravenous administration using in vivo 19F magnetic resonance spectroscopyThe British Journal of Radiology, 1990
- 19F MRS studies of fluoropyrimidine chemotherapy. A reviewNMR in Biomedicine, 1989
- Accelerated Iterative Reconstruction for Positron Emission Tomography Based on the EM Algorithm for Maximum Likelihood EstimationIEEE Transactions on Medical Imaging, 1986
- Nonlinear pharmacokinetic models for 5-fluorouracil in man: Intravenous and intraperitoneal routesClinical Pharmacology & Therapeutics, 1980
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957